Make Medicines Affordable
  • Home
  • About
  • Where we work
  • News
  • Strategies
  • Resources
  • Resources
    • Best practices and models
    • Community publications
    • Compulsory licencsing
    • COVID-19
    • GSIPA2M 2018
    • Hepatitis C
    • HIV
    • Patent law
    • Patent Opposition
    • Patents: the facts
    • Report
    • Research
    • Resource
    • Roadmap
    • TB
    • Trade agreements
    • TRIPS Agreement
    • Video

Campaign toolkit – our complete guide

Our toolkit will guide you through all the steps to challenge intellectual property barriers, from the life-cycle of a patent, the background, the processes, and what you can do.

Best practices and modelsPatents: the factsResearchResourceRoadmapTRIPS Agreement

English

01: Life-cycle of a drug: from the research to the patient

02: The problem of patents and access to medicines in middle income countries

03: Patents and access to medicines and other health technologies

05: TRIPS obligations and TRIPS Flexibilities on patents

07: Patent oppositions

08: The patenting process

09: Compulsory licensing

10: TRIPS+ provisions

11: How to conduct a patent search on a medicine

12: Finding the best strategy to overcome patent barriers and make medicines affordable

 

Keep in Touch

Our email newsletter has latest news on developments and campaign actions

Twitter

  • RT @MohgaKamalYanni: How wonderful to hear "Brazil is back" to global health. A great voice for the right of health for indigenous people…

    5 days ago

Make Medicines Affordable Twitter

Instagram

Make Medicines Affordable campaign challenges abus Make Medicines Affordable campaign challenges abuses of the #patent system. Our strategies include making successful legal and technical interventions, in-line with international trade agreements, and working to strengthen patent laws to create long-term change. #MedicineEqualityNow © Bangkok, Thailand, 2019. © @gemmataylorphoto / Make Medicines Affordable
"We need spread more information around HIV and en "We need spread more information around HIV and ensure access to affordable treatment". Theo Keborate. #Botswana, 2021 © Letso Leipego/Majority World/Make Medicines Affordable/2021
#EyesOnPharmaGreed. We have it, do you? #Medicin #EyesOnPharmaGreed. We have it, do you? #MedicineEqualityNow and #AbolishTRIPS are the only way out of the COVID-19 pandemics and others to come. Everyone everywhere has the right to survive. Everyone everywhere has the right to affordable treatments. @worldtradeorganization could end the pandemics now. Everyday it passes, the world looses more lives to a disease that already has a vaccine.
Who decides if you get a life-saving vaccine? Th Who decides if you get a life-saving vaccine? The world's essential medicines are controlled by a wealthy few, but it's time to take them back. Watch our animation to discover more. #MedicineEqualityNow #FightToSurvive #AbolishTRIPS

Make Medicines Affordable Instagram

Facebook

📌Addressing the Impact of COVID-19 on HIV and TB Services from a year of community-led monitoring of 29 health facilities in Malawi and South Africa.In this publication, we share:✅“the good”(the scaling of COVID-related adaptations to HIV and TB services and increased people-centeredness),❌“the bad”(continued COVID-related service disruptions and quality of care issues), and▪️▪️▪️“the unfinished business”(emerging advocacy priorities and change agendas)View the full resource here: itpcglobal.org/blog/resource/the-good-the-bad-the-unfinished-business/#Communityled #CLM #health #HIV #TB #COVID19 #WatchWhatMatters ... See MoreSee Less

The Good, the Bad, & the Unfinished Business

itpcglobal.org

4 days ago  ·  

ITPC global Facebook

© Copyright ITPC 2023 Cookies Media enquiries Contact us Website by Maraid Design

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}